nodes	percent_of_prediction	percent_of_DWPC	metapath
Flunisolide—Prednisone—prostate cancer	0.31	1	CrCtD
Flunisolide—NR3C1—prostate cancer	0.126	0.633	CbGaD
Flunisolide—CYP3A4—prostate cancer	0.073	0.367	CbGaD
Flunisolide—NR3C1—Prednisone—prostate cancer	0.032	0.187	CbGbCtD
Flunisolide—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0287	0.168	CbGbCtD
Flunisolide—CYP3A4—Bicalutamide—prostate cancer	0.0151	0.0883	CbGbCtD
Flunisolide—Ciclesonide—Prednisone—prostate cancer	0.0145	0.0691	CrCrCtD
Flunisolide—CYP3A4—Estramustine—prostate cancer	0.014	0.0821	CbGbCtD
Flunisolide—CYP3A4—Abiraterone—prostate cancer	0.0125	0.0731	CbGbCtD
Flunisolide—CYP3A4—Flutamide—prostate cancer	0.0125	0.0731	CbGbCtD
Flunisolide—Prednicarbate—Prednisone—prostate cancer	0.0114	0.0543	CrCrCtD
Flunisolide—Fluocortolone—Prednisone—prostate cancer	0.0111	0.0528	CrCrCtD
Flunisolide—Alclometasone—Prednisone—prostate cancer	0.0108	0.0513	CrCrCtD
Flunisolide—Amcinonide—Prednisone—prostate cancer	0.0105	0.0499	CrCrCtD
Flunisolide—Budesonide—Prednisone—prostate cancer	0.0105	0.0499	CrCrCtD
Flunisolide—Diflorasone—Prednisone—prostate cancer	0.0102	0.0486	CrCrCtD
Flunisolide—Desonide—Prednisone—prostate cancer	0.0102	0.0486	CrCrCtD
Flunisolide—Paramethasone—Prednisone—prostate cancer	0.00996	0.0474	CrCrCtD
Flunisolide—Desoximetasone—Prednisone—prostate cancer	0.00972	0.0463	CrCrCtD
Flunisolide—Fluorometholone—Prednisone—prostate cancer	0.00949	0.0452	CrCrCtD
Flunisolide—Loteprednol—Prednisone—prostate cancer	0.00949	0.0452	CrCrCtD
Flunisolide—Fluprednidene Acetate—Prednisone—prostate cancer	0.00949	0.0452	CrCrCtD
Flunisolide—Triamcinolone—Prednisone—prostate cancer	0.00949	0.0452	CrCrCtD
Flunisolide—Mometasone—Prednisone—prostate cancer	0.00949	0.0452	CrCrCtD
Flunisolide—Betamethasone—Prednisone—prostate cancer	0.00927	0.0441	CrCrCtD
Flunisolide—Rimexolone—Prednisone—prostate cancer	0.00927	0.0441	CrCrCtD
Flunisolide—Dexamethasone—Prednisone—prostate cancer	0.00927	0.0441	CrCrCtD
Flunisolide—CYP3A4—Cabazitaxel—prostate cancer	0.00924	0.0541	CbGbCtD
Flunisolide—CYP3A4—Estrone—prostate cancer	0.00903	0.0529	CbGbCtD
Flunisolide—Methylprednisolone—Prednisone—prostate cancer	0.00887	0.0422	CrCrCtD
Flunisolide—Prednisolone—Prednisone—prostate cancer	0.00868	0.0413	CrCrCtD
Flunisolide—Hydrocortisone—Prednisone—prostate cancer	0.00833	0.0397	CrCrCtD
Flunisolide—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00805	0.0471	CbGbCtD
Flunisolide—CYP3A4—Conjugated Estrogens—prostate cancer	0.00591	0.0346	CbGbCtD
Flunisolide—CYP3A4—Mitoxantrone—prostate cancer	0.00537	0.0314	CbGbCtD
Flunisolide—CYP3A4—Estradiol—prostate cancer	0.00519	0.0304	CbGbCtD
Flunisolide—CYP3A4—Prednisone—prostate cancer	0.00446	0.0261	CbGbCtD
Flunisolide—CYP3A4—Etoposide—prostate cancer	0.00339	0.0198	CbGbCtD
Flunisolide—CYP3A4—Docetaxel—prostate cancer	0.0031	0.0181	CbGbCtD
Flunisolide—CYP3A4—Doxorubicin—prostate cancer	0.00231	0.0135	CbGbCtD
Flunisolide—NR3C1—urine—prostate cancer	0.000811	0.209	CbGeAlD
Flunisolide—CYP3A4—urine—prostate cancer	0.000613	0.158	CbGeAlD
Flunisolide—SERPINA6—renal system—prostate cancer	0.000453	0.117	CbGeAlD
Flunisolide—SERPINA6—bone marrow—prostate cancer	0.000342	0.0882	CbGeAlD
Flunisolide—NR3C1—prostate gland—prostate cancer	0.000291	0.0749	CbGeAlD
Flunisolide—NR3C1—seminal vesicle—prostate cancer	0.000246	0.0634	CbGeAlD
Flunisolide—Amcinonide—ANXA1—prostate cancer	0.000227	0.0848	CrCbGaD
Flunisolide—NR3C1—epithelium—prostate cancer	0.000214	0.0551	CbGeAlD
Flunisolide—NR3C1—renal system—prostate cancer	0.000198	0.0511	CbGeAlD
Flunisolide—NR3C1—urethra—prostate cancer	0.000195	0.0502	CbGeAlD
Flunisolide—CYP3A4—renal system—prostate cancer	0.00015	0.0386	CbGeAlD
Flunisolide—NR3C1—bone marrow—prostate cancer	0.00015	0.0386	CbGeAlD
Flunisolide—NR3C1—testis—prostate cancer	0.000128	0.033	CbGeAlD
Flunisolide—Hydrocortisone—ANXA1—prostate cancer	9.57e-05	0.0357	CrCbGaD
Flunisolide—NR3C1—lymph node—prostate cancer	9.29e-05	0.0239	CbGeAlD
Flunisolide—Dexamethasone—CYP3A43—prostate cancer	9.02e-05	0.0337	CrCbGaD
Flunisolide—Difluprednate—NR3C1—prostate cancer	7.63e-05	0.0285	CrCbGaD
Flunisolide—Clocortolone—NR3C1—prostate cancer	7.39e-05	0.0276	CrCbGaD
Flunisolide—Prednicarbate—NR3C1—prostate cancer	7.39e-05	0.0276	CrCbGaD
Flunisolide—Dexamethasone—ANXA1—prostate cancer	7.13e-05	0.0266	CrCbGaD
Flunisolide—Diflorasone—NR3C1—prostate cancer	7e-05	0.0261	CrCbGaD
Flunisolide—Desonide—NR3C1—prostate cancer	7e-05	0.0261	CrCbGaD
Flunisolide—Desoximetasone—NR3C1—prostate cancer	6.82e-05	0.0255	CrCbGaD
Flunisolide—Loteprednol—NR3C1—prostate cancer	6.74e-05	0.0252	CrCbGaD
Flunisolide—Flurandrenolide—NR3C1—prostate cancer	5.98e-05	0.0223	CrCbGaD
Flunisolide—Flumethasone Pivalate—NR3C1—prostate cancer	5.87e-05	0.0219	CrCbGaD
Flunisolide—Halobetasol Propionate—NR3C1—prostate cancer	5.78e-05	0.0216	CrCbGaD
Flunisolide—Amcinonide—NR3C1—prostate cancer	5.37e-05	0.0201	CrCbGaD
Flunisolide—Budesonide—NR3C1—prostate cancer	5.37e-05	0.0201	CrCbGaD
Flunisolide—Fluticasone furoate—NR3C1—prostate cancer	5.27e-05	0.0197	CrCbGaD
Flunisolide—Mometasone—NR3C1—prostate cancer	5.11e-05	0.0191	CrCbGaD
Flunisolide—Rimexolone—NR3C1—prostate cancer	5.05e-05	0.0189	CrCbGaD
Flunisolide—Fluocinonide—NR3C1—prostate cancer	4.76e-05	0.0178	CrCbGaD
Flunisolide—Alclometasone—NR3C1—prostate cancer	4.63e-05	0.0173	CrCbGaD
Flunisolide—Fluocinolone Acetonide—NR3C1—prostate cancer	4.63e-05	0.0173	CrCbGaD
Flunisolide—Paramethasone—NR3C1—prostate cancer	4.45e-05	0.0166	CrCbGaD
Flunisolide—Ciclesonide—NR3C1—prostate cancer	4.38e-05	0.0164	CrCbGaD
Flunisolide—Fluorometholone—NR3C1—prostate cancer	4.35e-05	0.0162	CrCbGaD
Flunisolide—Fluticasone Propionate—CYP3A5—prostate cancer	4.24e-05	0.0158	CrCbGaD
Flunisolide—Methylprednisolone—NR3C1—prostate cancer	4.2e-05	0.0157	CrCbGaD
Flunisolide—Dexamethasone—CYP17A1—prostate cancer	4.09e-05	0.0153	CrCbGaD
Flunisolide—Prednisolone—CYP2A6—prostate cancer	3.84e-05	0.0143	CrCbGaD
Flunisolide—Hydrocortisone—SHBG—prostate cancer	3.81e-05	0.0142	CrCbGaD
Flunisolide—Betamethasone—CYP19A1—prostate cancer	3.58e-05	0.0134	CrCbGaD
Flunisolide—Triamcinolone—NR3C1—prostate cancer	3.54e-05	0.0132	CrCbGaD
Flunisolide—Palpitations—Capecitabine—prostate cancer	3.48e-05	0.000429	CcSEcCtD
Flunisolide—Decreased appetite—Etoposide—prostate cancer	3.47e-05	0.000428	CcSEcCtD
Flunisolide—Myalgia—Docetaxel—prostate cancer	3.46e-05	0.000427	CcSEcCtD
Flunisolide—Chest pain—Docetaxel—prostate cancer	3.46e-05	0.000427	CcSEcCtD
Flunisolide—Loss of consciousness—Capecitabine—prostate cancer	3.46e-05	0.000427	CcSEcCtD
Flunisolide—Asthenia—Mitoxantrone—prostate cancer	3.44e-05	0.000425	CcSEcCtD
Flunisolide—Fatigue—Etoposide—prostate cancer	3.44e-05	0.000424	CcSEcCtD
Flunisolide—Cough—Capecitabine—prostate cancer	3.43e-05	0.000424	CcSEcCtD
Flunisolide—Stomatitis—Epirubicin—prostate cancer	3.42e-05	0.000422	CcSEcCtD
Flunisolide—Constipation—Etoposide—prostate cancer	3.41e-05	0.000421	CcSEcCtD
Flunisolide—Pain—Etoposide—prostate cancer	3.41e-05	0.000421	CcSEcCtD
Flunisolide—Urinary tract infection—Epirubicin—prostate cancer	3.41e-05	0.000421	CcSEcCtD
Flunisolide—Conjunctivitis—Epirubicin—prostate cancer	3.41e-05	0.000421	CcSEcCtD
Flunisolide—Dizziness—Estradiol—prostate cancer	3.4e-05	0.00042	CcSEcCtD
Flunisolide—Hypertension—Capecitabine—prostate cancer	3.4e-05	0.000419	CcSEcCtD
Flunisolide—Upper respiratory tract infection—Doxorubicin—prostate cancer	3.38e-05	0.000417	CcSEcCtD
Flunisolide—Sweating—Epirubicin—prostate cancer	3.36e-05	0.000415	CcSEcCtD
Flunisolide—Myalgia—Capecitabine—prostate cancer	3.35e-05	0.000413	CcSEcCtD
Flunisolide—Chest pain—Capecitabine—prostate cancer	3.35e-05	0.000413	CcSEcCtD
Flunisolide—Anxiety—Capecitabine—prostate cancer	3.34e-05	0.000412	CcSEcCtD
Flunisolide—Oedema—Docetaxel—prostate cancer	3.32e-05	0.000409	CcSEcCtD
Flunisolide—Weight increased—Doxorubicin—prostate cancer	3.31e-05	0.000409	CcSEcCtD
Flunisolide—Discomfort—Capecitabine—prostate cancer	3.31e-05	0.000408	CcSEcCtD
Flunisolide—Epistaxis—Epirubicin—prostate cancer	3.31e-05	0.000408	CcSEcCtD
Flunisolide—Vision blurred—Prednisone—prostate cancer	3.3e-05	0.000408	CcSEcCtD
Flunisolide—Infection—Docetaxel—prostate cancer	3.29e-05	0.000407	CcSEcCtD
Flunisolide—Sinusitis—Epirubicin—prostate cancer	3.29e-05	0.000406	CcSEcCtD
Flunisolide—Feeling abnormal—Etoposide—prostate cancer	3.29e-05	0.000406	CcSEcCtD
Flunisolide—Diarrhoea—Mitoxantrone—prostate cancer	3.28e-05	0.000405	CcSEcCtD
Flunisolide—Vomiting—Estradiol—prostate cancer	3.27e-05	0.000404	CcSEcCtD
Flunisolide—Pneumonia—Doxorubicin—prostate cancer	3.26e-05	0.000403	CcSEcCtD
Flunisolide—Gastrointestinal pain—Etoposide—prostate cancer	3.26e-05	0.000403	CcSEcCtD
Flunisolide—Shock—Docetaxel—prostate cancer	3.26e-05	0.000403	CcSEcCtD
Flunisolide—Ill-defined disorder—Prednisone—prostate cancer	3.25e-05	0.000401	CcSEcCtD
Flunisolide—Rash—Estradiol—prostate cancer	3.25e-05	0.000401	CcSEcCtD
Flunisolide—Dermatitis—Estradiol—prostate cancer	3.24e-05	0.0004	CcSEcCtD
Flunisolide—Tachycardia—Docetaxel—prostate cancer	3.24e-05	0.000399	CcSEcCtD
Flunisolide—Headache—Estradiol—prostate cancer	3.23e-05	0.000398	CcSEcCtD
Flunisolide—Agitation—Prednisone—prostate cancer	3.22e-05	0.000397	CcSEcCtD
Flunisolide—Prednisone—NR3C1—prostate cancer	3.21e-05	0.012	CrCbGaD
Flunisolide—Oedema—Capecitabine—prostate cancer	3.21e-05	0.000396	CcSEcCtD
Flunisolide—Infection—Capecitabine—prostate cancer	3.19e-05	0.000394	CcSEcCtD
Flunisolide—Urticaria—Etoposide—prostate cancer	3.17e-05	0.000391	CcSEcCtD
Flunisolide—Fluticasone Propionate—NR3C1—prostate cancer	3.17e-05	0.0118	CrCbGaD
Flunisolide—Stomatitis—Doxorubicin—prostate cancer	3.16e-05	0.00039	CcSEcCtD
Flunisolide—Malaise—Prednisone—prostate cancer	3.16e-05	0.00039	CcSEcCtD
Flunisolide—Shock—Capecitabine—prostate cancer	3.16e-05	0.00039	CcSEcCtD
Flunisolide—Rhinitis—Epirubicin—prostate cancer	3.16e-05	0.000389	CcSEcCtD
Flunisolide—Body temperature increased—Etoposide—prostate cancer	3.15e-05	0.000389	CcSEcCtD
Flunisolide—Abdominal pain—Etoposide—prostate cancer	3.15e-05	0.000389	CcSEcCtD
Flunisolide—Urinary tract infection—Doxorubicin—prostate cancer	3.15e-05	0.000389	CcSEcCtD
Flunisolide—Conjunctivitis—Doxorubicin—prostate cancer	3.15e-05	0.000389	CcSEcCtD
Flunisolide—Vertigo—Prednisone—prostate cancer	3.15e-05	0.000388	CcSEcCtD
Flunisolide—Syncope—Prednisone—prostate cancer	3.14e-05	0.000388	CcSEcCtD
Flunisolide—Tachycardia—Capecitabine—prostate cancer	3.13e-05	0.000387	CcSEcCtD
Flunisolide—Hypoaesthesia—Epirubicin—prostate cancer	3.13e-05	0.000387	CcSEcCtD
Flunisolide—Pharyngitis—Epirubicin—prostate cancer	3.12e-05	0.000386	CcSEcCtD
Flunisolide—Budesonide—CYP3A4—prostate cancer	3.11e-05	0.0116	CrCbGaD
Flunisolide—Sweating—Doxorubicin—prostate cancer	3.11e-05	0.000384	CcSEcCtD
Flunisolide—Hyperhidrosis—Capecitabine—prostate cancer	3.1e-05	0.000383	CcSEcCtD
Flunisolide—Oedema peripheral—Epirubicin—prostate cancer	3.1e-05	0.000383	CcSEcCtD
Flunisolide—Loss of consciousness—Prednisone—prostate cancer	3.08e-05	0.00038	CcSEcCtD
Flunisolide—Epistaxis—Doxorubicin—prostate cancer	3.06e-05	0.000378	CcSEcCtD
Flunisolide—Nausea—Estradiol—prostate cancer	3.06e-05	0.000377	CcSEcCtD
Flunisolide—Fluticasone furoate—CYP3A4—prostate cancer	3.05e-05	0.0114	CrCbGaD
Flunisolide—Vomiting—Mitoxantrone—prostate cancer	3.05e-05	0.000376	CcSEcCtD
Flunisolide—Sinusitis—Doxorubicin—prostate cancer	3.04e-05	0.000376	CcSEcCtD
Flunisolide—Hydrocortisone—CYP3A5—prostate cancer	3.03e-05	0.0113	CrCbGaD
Flunisolide—Hypertension—Prednisone—prostate cancer	3.03e-05	0.000373	CcSEcCtD
Flunisolide—Rash—Mitoxantrone—prostate cancer	3.02e-05	0.000373	CcSEcCtD
Flunisolide—Dermatitis—Mitoxantrone—prostate cancer	3.02e-05	0.000373	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Docetaxel—prostate cancer	3.02e-05	0.000373	CcSEcCtD
Flunisolide—Headache—Mitoxantrone—prostate cancer	3.01e-05	0.000371	CcSEcCtD
Flunisolide—Insomnia—Docetaxel—prostate cancer	3e-05	0.00037	CcSEcCtD
Flunisolide—Myalgia—Prednisone—prostate cancer	2.98e-05	0.000368	CcSEcCtD
Flunisolide—Erythema multiforme—Epirubicin—prostate cancer	2.98e-05	0.000367	CcSEcCtD
Flunisolide—Anxiety—Prednisone—prostate cancer	2.97e-05	0.000367	CcSEcCtD
Flunisolide—Prednisolone—NR3C1—prostate cancer	2.96e-05	0.0111	CrCbGaD
Flunisolide—Dyspnoea—Docetaxel—prostate cancer	2.96e-05	0.000365	CcSEcCtD
Flunisolide—Discomfort—Prednisone—prostate cancer	2.95e-05	0.000364	CcSEcCtD
Flunisolide—Hypersensitivity—Etoposide—prostate cancer	2.94e-05	0.000363	CcSEcCtD
Flunisolide—Prednisone—CYP2C19—prostate cancer	2.93e-05	0.0109	CrCbGaD
Flunisolide—Musculoskeletal discomfort—Capecitabine—prostate cancer	2.93e-05	0.000361	CcSEcCtD
Flunisolide—Rhinitis—Doxorubicin—prostate cancer	2.92e-05	0.00036	CcSEcCtD
Flunisolide—Dyspepsia—Docetaxel—prostate cancer	2.92e-05	0.00036	CcSEcCtD
Flunisolide—Insomnia—Capecitabine—prostate cancer	2.9e-05	0.000358	CcSEcCtD
Flunisolide—Betamethasone—NR3C1—prostate cancer	2.9e-05	0.0108	CrCbGaD
Flunisolide—Hypoaesthesia—Doxorubicin—prostate cancer	2.9e-05	0.000358	CcSEcCtD
Flunisolide—Pharyngitis—Doxorubicin—prostate cancer	2.89e-05	0.000357	CcSEcCtD
Flunisolide—Decreased appetite—Docetaxel—prostate cancer	2.88e-05	0.000356	CcSEcCtD
Flunisolide—Oedema peripheral—Doxorubicin—prostate cancer	2.87e-05	0.000354	CcSEcCtD
Flunisolide—Asthenia—Etoposide—prostate cancer	2.86e-05	0.000353	CcSEcCtD
Flunisolide—Dyspnoea—Capecitabine—prostate cancer	2.86e-05	0.000353	CcSEcCtD
Flunisolide—Oedema—Prednisone—prostate cancer	2.86e-05	0.000353	CcSEcCtD
Flunisolide—Fatigue—Docetaxel—prostate cancer	2.86e-05	0.000353	CcSEcCtD
Flunisolide—Nausea—Mitoxantrone—prostate cancer	2.85e-05	0.000352	CcSEcCtD
Flunisolide—Infection—Prednisone—prostate cancer	2.84e-05	0.000351	CcSEcCtD
Flunisolide—Dexamethasone—CYP1B1—prostate cancer	2.84e-05	0.0106	CrCbGaD
Flunisolide—Constipation—Docetaxel—prostate cancer	2.84e-05	0.00035	CcSEcCtD
Flunisolide—Pain—Docetaxel—prostate cancer	2.84e-05	0.00035	CcSEcCtD
Flunisolide—Dyspepsia—Capecitabine—prostate cancer	2.83e-05	0.000349	CcSEcCtD
Flunisolide—Chills—Epirubicin—prostate cancer	2.82e-05	0.000349	CcSEcCtD
Flunisolide—Pruritus—Etoposide—prostate cancer	2.82e-05	0.000348	CcSEcCtD
Flunisolide—Shock—Prednisone—prostate cancer	2.81e-05	0.000347	CcSEcCtD
Flunisolide—Tachycardia—Prednisone—prostate cancer	2.79e-05	0.000344	CcSEcCtD
Flunisolide—Decreased appetite—Capecitabine—prostate cancer	2.79e-05	0.000344	CcSEcCtD
Flunisolide—Fatigue—Capecitabine—prostate cancer	2.77e-05	0.000342	CcSEcCtD
Flunisolide—Hyperhidrosis—Prednisone—prostate cancer	2.76e-05	0.000341	CcSEcCtD
Flunisolide—Erythema multiforme—Doxorubicin—prostate cancer	2.75e-05	0.00034	CcSEcCtD
Flunisolide—Pain—Capecitabine—prostate cancer	2.75e-05	0.000339	CcSEcCtD
Flunisolide—Constipation—Capecitabine—prostate cancer	2.75e-05	0.000339	CcSEcCtD
Flunisolide—Malnutrition—Epirubicin—prostate cancer	2.74e-05	0.000338	CcSEcCtD
Flunisolide—Feeling abnormal—Docetaxel—prostate cancer	2.73e-05	0.000337	CcSEcCtD
Flunisolide—Diarrhoea—Etoposide—prostate cancer	2.73e-05	0.000337	CcSEcCtD
Flunisolide—Gastrointestinal pain—Docetaxel—prostate cancer	2.71e-05	0.000335	CcSEcCtD
Flunisolide—Alclometasone—CYP3A4—prostate cancer	2.68e-05	0.01	CrCbGaD
Flunisolide—Dysgeusia—Epirubicin—prostate cancer	2.68e-05	0.000331	CcSEcCtD
Flunisolide—CYP3A4—Biological oxidations—CYP7B1—prostate cancer	2.68e-05	0.00119	CbGpPWpGaD
Flunisolide—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—prostate cancer	2.68e-05	0.00119	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—IL2—prostate cancer	2.67e-05	0.00118	CbGpPWpGaD
Flunisolide—Back pain—Epirubicin—prostate cancer	2.65e-05	0.000327	CcSEcCtD
Flunisolide—Feeling abnormal—Capecitabine—prostate cancer	2.65e-05	0.000326	CcSEcCtD
Flunisolide—CYP3A4—Metapathway biotransformation—CYP7B1—prostate cancer	2.65e-05	0.00118	CbGpPWpGaD
Flunisolide—Dizziness—Etoposide—prostate cancer	2.64e-05	0.000326	CcSEcCtD
Flunisolide—Gastrointestinal pain—Capecitabine—prostate cancer	2.63e-05	0.000324	CcSEcCtD
Flunisolide—Abdominal pain—Docetaxel—prostate cancer	2.62e-05	0.000323	CcSEcCtD
Flunisolide—Body temperature increased—Docetaxel—prostate cancer	2.62e-05	0.000323	CcSEcCtD
Flunisolide—CYP3A4—Biological oxidations—SULT1E1—prostate cancer	2.61e-05	0.00116	CbGpPWpGaD
Flunisolide—Chills—Doxorubicin—prostate cancer	2.61e-05	0.000323	CcSEcCtD
Flunisolide—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—prostate cancer	2.61e-05	0.00116	CbGpPWpGaD
Flunisolide—Musculoskeletal discomfort—Prednisone—prostate cancer	2.61e-05	0.000322	CcSEcCtD
Flunisolide—NR3C1—Adipogenesis—IRS1—prostate cancer	2.59e-05	0.00115	CbGpPWpGaD
Flunisolide—Insomnia—Prednisone—prostate cancer	2.59e-05	0.000319	CcSEcCtD
Flunisolide—CYP3A4—Cytochrome P450 - arranged by substrate type—NCOA1—prostate cancer	2.59e-05	0.00115	CbGpPWpGaD
Flunisolide—Vision blurred—Epirubicin—prostate cancer	2.58e-05	0.000319	CcSEcCtD
Flunisolide—Paramethasone—CYP3A4—prostate cancer	2.58e-05	0.00964	CrCbGaD
Flunisolide—CYP3A4—Metapathway biotransformation—SULT1E1—prostate cancer	2.58e-05	0.00115	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—NFIC—prostate cancer	2.57e-05	0.00114	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—HIF1A—prostate cancer	2.57e-05	0.00114	CbGpPWpGaD
Flunisolide—Urticaria—Capecitabine—prostate cancer	2.55e-05	0.000315	CcSEcCtD
Flunisolide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—prostate cancer	2.55e-05	0.00113	CbGpPWpGaD
Flunisolide—Ill-defined disorder—Epirubicin—prostate cancer	2.54e-05	0.000314	CcSEcCtD
Flunisolide—CYP3A4—Tryptophan metabolism—CYP1A1—prostate cancer	2.54e-05	0.00113	CbGpPWpGaD
Flunisolide—Ciclesonide—CYP3A4—prostate cancer	2.54e-05	0.00948	CrCbGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—prostate cancer	2.54e-05	0.00113	CbGpPWpGaD
Flunisolide—Abdominal pain—Capecitabine—prostate cancer	2.54e-05	0.000313	CcSEcCtD
Flunisolide—Body temperature increased—Capecitabine—prostate cancer	2.54e-05	0.000313	CcSEcCtD
Flunisolide—Vomiting—Etoposide—prostate cancer	2.54e-05	0.000313	CcSEcCtD
Flunisolide—Malnutrition—Doxorubicin—prostate cancer	2.54e-05	0.000313	CcSEcCtD
Flunisolide—Fluorometholone—CYP3A4—prostate cancer	2.52e-05	0.00941	CrCbGaD
Flunisolide—Agitation—Epirubicin—prostate cancer	2.52e-05	0.000311	CcSEcCtD
Flunisolide—Dyspepsia—Prednisone—prostate cancer	2.52e-05	0.000311	CcSEcCtD
Flunisolide—Rash—Etoposide—prostate cancer	2.52e-05	0.00031	CcSEcCtD
Flunisolide—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—prostate cancer	2.52e-05	0.00112	CbGpPWpGaD
Flunisolide—Dermatitis—Etoposide—prostate cancer	2.51e-05	0.00031	CcSEcCtD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—prostate cancer	2.51e-05	0.00112	CbGpPWpGaD
Flunisolide—Headache—Etoposide—prostate cancer	2.5e-05	0.000308	CcSEcCtD
Flunisolide—CYP3A4—Phase 1 - Functionalization of compounds—NCOA2—prostate cancer	2.49e-05	0.00111	CbGpPWpGaD
Flunisolide—Decreased appetite—Prednisone—prostate cancer	2.49e-05	0.000307	CcSEcCtD
Flunisolide—Dysgeusia—Doxorubicin—prostate cancer	2.48e-05	0.000306	CcSEcCtD
Flunisolide—NR3C1—Adipogenesis—INS—prostate cancer	2.48e-05	0.0011	CbGpPWpGaD
Flunisolide—Malaise—Epirubicin—prostate cancer	2.47e-05	0.000305	CcSEcCtD
Flunisolide—Fatigue—Prednisone—prostate cancer	2.47e-05	0.000304	CcSEcCtD
Flunisolide—Vertigo—Epirubicin—prostate cancer	2.46e-05	0.000304	CcSEcCtD
Flunisolide—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—prostate cancer	2.46e-05	0.00109	CbGpPWpGaD
Flunisolide—Syncope—Epirubicin—prostate cancer	2.46e-05	0.000303	CcSEcCtD
Flunisolide—Back pain—Doxorubicin—prostate cancer	2.45e-05	0.000303	CcSEcCtD
Flunisolide—Constipation—Prednisone—prostate cancer	2.45e-05	0.000302	CcSEcCtD
Flunisolide—Hypersensitivity—Docetaxel—prostate cancer	2.44e-05	0.000301	CcSEcCtD
Flunisolide—Methylprednisolone—CYP3A4—prostate cancer	2.43e-05	0.00909	CrCbGaD
Flunisolide—Palpitations—Epirubicin—prostate cancer	2.42e-05	0.000299	CcSEcCtD
Flunisolide—NR3C1—Gene Expression—RPN2—prostate cancer	2.42e-05	0.00107	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—prostate cancer	2.42e-05	0.00107	CbGpPWpGaD
Flunisolide—NR3C1—Endoderm Differentiation—TGFB1—prostate cancer	2.41e-05	0.00107	CbGpPWpGaD
Flunisolide—Loss of consciousness—Epirubicin—prostate cancer	2.41e-05	0.000297	CcSEcCtD
Flunisolide—NR3C1—Adipogenesis—IGF1—prostate cancer	2.4e-05	0.00107	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—EP300—prostate cancer	2.39e-05	0.00106	CbGpPWpGaD
Flunisolide—Cough—Epirubicin—prostate cancer	2.39e-05	0.000295	CcSEcCtD
Flunisolide—Vision blurred—Doxorubicin—prostate cancer	2.39e-05	0.000295	CcSEcCtD
Flunisolide—Asthenia—Docetaxel—prostate cancer	2.38e-05	0.000294	CcSEcCtD
Flunisolide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—prostate cancer	2.38e-05	0.00106	CbGpPWpGaD
Flunisolide—Nausea—Etoposide—prostate cancer	2.37e-05	0.000292	CcSEcCtD
Flunisolide—Hypertension—Epirubicin—prostate cancer	2.37e-05	0.000292	CcSEcCtD
Flunisolide—Hypersensitivity—Capecitabine—prostate cancer	2.37e-05	0.000292	CcSEcCtD
Flunisolide—NR3C1—AP-1 transcription factor network—MYC—prostate cancer	2.37e-05	0.00105	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—TGFB1—prostate cancer	2.36e-05	0.00105	CbGpPWpGaD
Flunisolide—Feeling abnormal—Prednisone—prostate cancer	2.36e-05	0.000291	CcSEcCtD
Flunisolide—Ill-defined disorder—Doxorubicin—prostate cancer	2.35e-05	0.00029	CcSEcCtD
Flunisolide—Pruritus—Docetaxel—prostate cancer	2.35e-05	0.00029	CcSEcCtD
Flunisolide—Gastrointestinal pain—Prednisone—prostate cancer	2.34e-05	0.000289	CcSEcCtD
Flunisolide—Chest pain—Epirubicin—prostate cancer	2.33e-05	0.000288	CcSEcCtD
Flunisolide—Myalgia—Epirubicin—prostate cancer	2.33e-05	0.000288	CcSEcCtD
Flunisolide—Agitation—Doxorubicin—prostate cancer	2.33e-05	0.000288	CcSEcCtD
Flunisolide—Anxiety—Epirubicin—prostate cancer	2.33e-05	0.000287	CcSEcCtD
Flunisolide—NR3C1—Generic Transcription Pathway—NPPA—prostate cancer	2.32e-05	0.00103	CbGpPWpGaD
Flunisolide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—prostate cancer	2.32e-05	0.00103	CbGpPWpGaD
Flunisolide—Discomfort—Epirubicin—prostate cancer	2.31e-05	0.000284	CcSEcCtD
Flunisolide—Asthenia—Capecitabine—prostate cancer	2.3e-05	0.000284	CcSEcCtD
Flunisolide—CYP3A4—Biological oxidations—CYP3A5—prostate cancer	2.3e-05	0.00102	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—QARS—prostate cancer	2.29e-05	0.00102	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—MED12—prostate cancer	2.29e-05	0.00102	CbGpPWpGaD
Flunisolide—Malaise—Doxorubicin—prostate cancer	2.29e-05	0.000282	CcSEcCtD
Flunisolide—Vertigo—Doxorubicin—prostate cancer	2.28e-05	0.000281	CcSEcCtD
Flunisolide—NR3C1—Adipogenesis—SERPINE1—prostate cancer	2.28e-05	0.00101	CbGpPWpGaD
Flunisolide—Syncope—Doxorubicin—prostate cancer	2.27e-05	0.000281	CcSEcCtD
Flunisolide—Urticaria—Prednisone—prostate cancer	2.27e-05	0.00028	CcSEcCtD
Flunisolide—Pruritus—Capecitabine—prostate cancer	2.27e-05	0.00028	CcSEcCtD
Flunisolide—CYP3A4—Metapathway biotransformation—CYP3A5—prostate cancer	2.27e-05	0.00101	CbGpPWpGaD
Flunisolide—Diarrhoea—Docetaxel—prostate cancer	2.27e-05	0.00028	CcSEcCtD
Flunisolide—Hydrocortisone—NR3C1—prostate cancer	2.26e-05	0.00846	CrCbGaD
Flunisolide—Abdominal pain—Prednisone—prostate cancer	2.26e-05	0.000279	CcSEcCtD
Flunisolide—Body temperature increased—Prednisone—prostate cancer	2.26e-05	0.000279	CcSEcCtD
Flunisolide—Dexamethasone—CYP3A5—prostate cancer	2.26e-05	0.00844	CrCbGaD
Flunisolide—Palpitations—Doxorubicin—prostate cancer	2.24e-05	0.000277	CcSEcCtD
Flunisolide—Oedema—Epirubicin—prostate cancer	2.24e-05	0.000276	CcSEcCtD
Flunisolide—Loss of consciousness—Doxorubicin—prostate cancer	2.23e-05	0.000275	CcSEcCtD
Flunisolide—CYP3A4—Biological oxidations—GSTA3—prostate cancer	2.22e-05	0.000988	CbGpPWpGaD
Flunisolide—Infection—Epirubicin—prostate cancer	2.22e-05	0.000274	CcSEcCtD
Flunisolide—Cough—Doxorubicin—prostate cancer	2.21e-05	0.000273	CcSEcCtD
Flunisolide—Shock—Epirubicin—prostate cancer	2.2e-05	0.000272	CcSEcCtD
Flunisolide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—prostate cancer	2.2e-05	0.000977	CbGpPWpGaD
Flunisolide—Diarrhoea—Capecitabine—prostate cancer	2.2e-05	0.000271	CcSEcCtD
Flunisolide—Dizziness—Docetaxel—prostate cancer	2.19e-05	0.000271	CcSEcCtD
Flunisolide—CYP3A4—Metapathway biotransformation—GSTA3—prostate cancer	2.19e-05	0.000974	CbGpPWpGaD
Flunisolide—Hypertension—Doxorubicin—prostate cancer	2.19e-05	0.00027	CcSEcCtD
Flunisolide—Dexamethasone—CYP2A6—prostate cancer	2.19e-05	0.00817	CrCbGaD
Flunisolide—Tachycardia—Epirubicin—prostate cancer	2.18e-05	0.000269	CcSEcCtD
Flunisolide—Hyperhidrosis—Epirubicin—prostate cancer	2.16e-05	0.000267	CcSEcCtD
Flunisolide—Chest pain—Doxorubicin—prostate cancer	2.16e-05	0.000266	CcSEcCtD
Flunisolide—Myalgia—Doxorubicin—prostate cancer	2.16e-05	0.000266	CcSEcCtD
Flunisolide—Anxiety—Doxorubicin—prostate cancer	2.15e-05	0.000265	CcSEcCtD
Flunisolide—Discomfort—Doxorubicin—prostate cancer	2.13e-05	0.000263	CcSEcCtD
Flunisolide—Dizziness—Capecitabine—prostate cancer	2.12e-05	0.000262	CcSEcCtD
Flunisolide—Vomiting—Docetaxel—prostate cancer	2.11e-05	0.00026	CcSEcCtD
Flunisolide—Hypersensitivity—Prednisone—prostate cancer	2.11e-05	0.00026	CcSEcCtD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—prostate cancer	2.1e-05	0.000935	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—CREBBP—prostate cancer	2.1e-05	0.000933	CbGpPWpGaD
Flunisolide—CYP3A4—Phase 1 - Functionalization of compounds—NCOA1—prostate cancer	2.1e-05	0.000932	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—TBX5—prostate cancer	2.1e-05	0.000932	CbGpPWpGaD
Flunisolide—Rash—Docetaxel—prostate cancer	2.09e-05	0.000258	CcSEcCtD
Flunisolide—Dermatitis—Docetaxel—prostate cancer	2.09e-05	0.000258	CcSEcCtD
Flunisolide—Dexamethasone—CYP19A1—prostate cancer	2.08e-05	0.00778	CrCbGaD
Flunisolide—Headache—Docetaxel—prostate cancer	2.08e-05	0.000256	CcSEcCtD
Flunisolide—Oedema—Doxorubicin—prostate cancer	2.07e-05	0.000255	CcSEcCtD
Flunisolide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—prostate cancer	2.07e-05	0.000918	CbGpPWpGaD
Flunisolide—Infection—Doxorubicin—prostate cancer	2.06e-05	0.000254	CcSEcCtD
Flunisolide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—prostate cancer	2.05e-05	0.000913	CbGpPWpGaD
Flunisolide—Triamcinolone—CYP3A4—prostate cancer	2.05e-05	0.00767	CrCbGaD
Flunisolide—Asthenia—Prednisone—prostate cancer	2.05e-05	0.000253	CcSEcCtD
Flunisolide—Vomiting—Capecitabine—prostate cancer	2.04e-05	0.000252	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.04e-05	0.000251	CcSEcCtD
Flunisolide—Shock—Doxorubicin—prostate cancer	2.04e-05	0.000251	CcSEcCtD
Flunisolide—CYP3A4—Biological oxidations—TBXAS1—prostate cancer	2.03e-05	0.000903	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—GSTA4—prostate cancer	2.03e-05	0.000903	CbGpPWpGaD
Flunisolide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—prostate cancer	2.03e-05	0.000901	CbGpPWpGaD
Flunisolide—Rash—Capecitabine—prostate cancer	2.02e-05	0.00025	CcSEcCtD
Flunisolide—Pruritus—Prednisone—prostate cancer	2.02e-05	0.00025	CcSEcCtD
Flunisolide—Insomnia—Epirubicin—prostate cancer	2.02e-05	0.00025	CcSEcCtD
Flunisolide—Dermatitis—Capecitabine—prostate cancer	2.02e-05	0.00025	CcSEcCtD
Flunisolide—Tachycardia—Doxorubicin—prostate cancer	2.02e-05	0.000249	CcSEcCtD
Flunisolide—Headache—Capecitabine—prostate cancer	2.01e-05	0.000248	CcSEcCtD
Flunisolide—Triamcinolone—PTGS2—prostate cancer	2.01e-05	0.00751	CrCbGaD
Flunisolide—CYP3A4—Metapathway biotransformation—GSTA4—prostate cancer	2e-05	0.000891	CbGpPWpGaD
Flunisolide—Hyperhidrosis—Doxorubicin—prostate cancer	2e-05	0.000247	CcSEcCtD
Flunisolide—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—prostate cancer	1.99e-05	0.000886	CbGpPWpGaD
Flunisolide—Dyspnoea—Epirubicin—prostate cancer	1.99e-05	0.000246	CcSEcCtD
Flunisolide—CYP3A4—Biological oxidations—GSTA2—prostate cancer	1.98e-05	0.00088	CbGpPWpGaD
Flunisolide—Nausea—Docetaxel—prostate cancer	1.97e-05	0.000243	CcSEcCtD
Flunisolide—Dyspepsia—Epirubicin—prostate cancer	1.97e-05	0.000243	CcSEcCtD
Flunisolide—CYP3A4—Biological oxidations—SULT1A1—prostate cancer	1.96e-05	0.00087	CbGpPWpGaD
Flunisolide—Diarrhoea—Prednisone—prostate cancer	1.96e-05	0.000241	CcSEcCtD
Flunisolide—NR3C1—Gene Expression—EIF3H—prostate cancer	1.95e-05	0.000866	CbGpPWpGaD
Flunisolide—Decreased appetite—Epirubicin—prostate cancer	1.94e-05	0.00024	CcSEcCtD
Flunisolide—NR3C1—AP-1 transcription factor network—TP53—prostate cancer	1.94e-05	0.000863	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—SULT1A1—prostate cancer	1.93e-05	0.000858	CbGpPWpGaD
Flunisolide—Fatigue—Epirubicin—prostate cancer	1.93e-05	0.000238	CcSEcCtD
Flunisolide—Pain—Epirubicin—prostate cancer	1.91e-05	0.000236	CcSEcCtD
Flunisolide—Constipation—Epirubicin—prostate cancer	1.91e-05	0.000236	CcSEcCtD
Flunisolide—CYP3A4—Biological oxidations—GSTA1—prostate cancer	1.91e-05	0.000849	CbGpPWpGaD
Flunisolide—Nausea—Capecitabine—prostate cancer	1.91e-05	0.000235	CcSEcCtD
Flunisolide—Dizziness—Prednisone—prostate cancer	1.89e-05	0.000233	CcSEcCtD
Flunisolide—CYP3A4—Biological oxidations—GSTO1—prostate cancer	1.89e-05	0.00084	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—NAT2—prostate cancer	1.89e-05	0.00084	CbGpPWpGaD
Flunisolide—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.89e-05	0.000233	CcSEcCtD
Flunisolide—Insomnia—Doxorubicin—prostate cancer	1.87e-05	0.000231	CcSEcCtD
Flunisolide—CYP3A4—Metapathway biotransformation—NAT2—prostate cancer	1.86e-05	0.000828	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—GSTO1—prostate cancer	1.86e-05	0.000828	CbGpPWpGaD
Flunisolide—Prednisone—CYP3A4—prostate cancer	1.86e-05	0.00696	CrCbGaD
Flunisolide—Dyspnoea—Doxorubicin—prostate cancer	1.85e-05	0.000228	CcSEcCtD
Flunisolide—Feeling abnormal—Epirubicin—prostate cancer	1.84e-05	0.000227	CcSEcCtD
Flunisolide—Fluticasone Propionate—CYP3A4—prostate cancer	1.84e-05	0.00686	CrCbGaD
Flunisolide—Gastrointestinal pain—Epirubicin—prostate cancer	1.83e-05	0.000226	CcSEcCtD
Flunisolide—NR3C1—Generic Transcription Pathway—NCOA2—prostate cancer	1.82e-05	0.000811	CbGpPWpGaD
Flunisolide—Dyspepsia—Doxorubicin—prostate cancer	1.82e-05	0.000225	CcSEcCtD
Flunisolide—Vomiting—Prednisone—prostate cancer	1.82e-05	0.000224	CcSEcCtD
Flunisolide—CYP3A4—Biological oxidations—CYP2C18—prostate cancer	1.81e-05	0.000805	CbGpPWpGaD
Flunisolide—Rash—Prednisone—prostate cancer	1.8e-05	0.000223	CcSEcCtD
Flunisolide—Dermatitis—Prednisone—prostate cancer	1.8e-05	0.000222	CcSEcCtD
Flunisolide—Decreased appetite—Doxorubicin—prostate cancer	1.8e-05	0.000222	CcSEcCtD
Flunisolide—Headache—Prednisone—prostate cancer	1.79e-05	0.000221	CcSEcCtD
Flunisolide—CYP3A4—Metapathway biotransformation—CYP2C18—prostate cancer	1.79e-05	0.000794	CbGpPWpGaD
Flunisolide—Fatigue—Doxorubicin—prostate cancer	1.78e-05	0.00022	CcSEcCtD
Flunisolide—NR3C1—Adipogenesis—CTNNB1—prostate cancer	1.78e-05	0.000791	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—IL6—prostate cancer	1.78e-05	0.00079	CbGpPWpGaD
Flunisolide—Urticaria—Epirubicin—prostate cancer	1.78e-05	0.000219	CcSEcCtD
Flunisolide—Pain—Doxorubicin—prostate cancer	1.77e-05	0.000218	CcSEcCtD
Flunisolide—Constipation—Doxorubicin—prostate cancer	1.77e-05	0.000218	CcSEcCtD
Flunisolide—Body temperature increased—Epirubicin—prostate cancer	1.77e-05	0.000218	CcSEcCtD
Flunisolide—Abdominal pain—Epirubicin—prostate cancer	1.77e-05	0.000218	CcSEcCtD
Flunisolide—NR3C1—Generic Transcription Pathway—PARP1—prostate cancer	1.76e-05	0.000783	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—CDKN1A—prostate cancer	1.74e-05	0.000773	CbGpPWpGaD
Flunisolide—Prednisolone—CYP3A4—prostate cancer	1.72e-05	0.00641	CrCbGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—TP53—prostate cancer	1.71e-05	0.000761	CbGpPWpGaD
Flunisolide—Feeling abnormal—Doxorubicin—prostate cancer	1.71e-05	0.00021	CcSEcCtD
Flunisolide—Nausea—Prednisone—prostate cancer	1.7e-05	0.00021	CcSEcCtD
Flunisolide—Gastrointestinal pain—Doxorubicin—prostate cancer	1.69e-05	0.000209	CcSEcCtD
Flunisolide—Dexamethasone—NR3C1—prostate cancer	1.69e-05	0.0063	CrCbGaD
Flunisolide—CYP3A4—Biological oxidations—SULT2A1—prostate cancer	1.68e-05	0.000749	CbGpPWpGaD
Flunisolide—Betamethasone—CYP3A4—prostate cancer	1.68e-05	0.00628	CrCbGaD
Flunisolide—NR3C1—Generic Transcription Pathway—ESR2—prostate cancer	1.67e-05	0.000741	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—CXCL8—prostate cancer	1.67e-05	0.000741	CbGpPWpGaD
Flunisolide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—prostate cancer	1.67e-05	0.00074	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—SULT2A1—prostate cancer	1.66e-05	0.000738	CbGpPWpGaD
Flunisolide—Hypersensitivity—Epirubicin—prostate cancer	1.65e-05	0.000203	CcSEcCtD
Flunisolide—Betamethasone—PTGS2—prostate cancer	1.65e-05	0.00615	CrCbGaD
Flunisolide—Urticaria—Doxorubicin—prostate cancer	1.64e-05	0.000203	CcSEcCtD
Flunisolide—Abdominal pain—Doxorubicin—prostate cancer	1.64e-05	0.000202	CcSEcCtD
Flunisolide—Body temperature increased—Doxorubicin—prostate cancer	1.64e-05	0.000202	CcSEcCtD
Flunisolide—Asthenia—Epirubicin—prostate cancer	1.6e-05	0.000198	CcSEcCtD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—CASP3—prostate cancer	1.6e-05	0.000709	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—MBD2—prostate cancer	1.59e-05	0.000706	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—TET2—prostate cancer	1.59e-05	0.000706	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—GPX3—prostate cancer	1.58e-05	0.000704	CbGpPWpGaD
Flunisolide—Pruritus—Epirubicin—prostate cancer	1.58e-05	0.000195	CcSEcCtD
Flunisolide—CYP3A4—Tryptophan metabolism—MDM2—prostate cancer	1.57e-05	0.000697	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—IL6—prostate cancer	1.57e-05	0.000696	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—RPL12—prostate cancer	1.56e-05	0.000692	CbGpPWpGaD
Flunisolide—Dexamethasone—CYP2E1—prostate cancer	1.55e-05	0.0058	CrCbGaD
Flunisolide—NR3C1—Adipogenesis—STAT3—prostate cancer	1.55e-05	0.000689	CbGpPWpGaD
Flunisolide—Dexamethasone—CYP2C19—prostate cancer	1.54e-05	0.00575	CrCbGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—CTNNB1—prostate cancer	1.54e-05	0.000684	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—NCOA1—prostate cancer	1.54e-05	0.000683	CbGpPWpGaD
Flunisolide—Dexamethasone—CYP1A1—prostate cancer	1.53e-05	0.00572	CrCbGaD
Flunisolide—Diarrhoea—Epirubicin—prostate cancer	1.53e-05	0.000189	CcSEcCtD
Flunisolide—Hypersensitivity—Doxorubicin—prostate cancer	1.52e-05	0.000188	CcSEcCtD
Flunisolide—CYP3A4—Biological oxidations—HPGDS—prostate cancer	1.51e-05	0.000671	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—CYP2C19—prostate cancer	1.5e-05	0.000667	CbGpPWpGaD
Flunisolide—Asthenia—Doxorubicin—prostate cancer	1.48e-05	0.000183	CcSEcCtD
Flunisolide—CYP3A4—Metapathway biotransformation—CYP2C19—prostate cancer	1.48e-05	0.000658	CbGpPWpGaD
Flunisolide—Dizziness—Epirubicin—prostate cancer	1.48e-05	0.000183	CcSEcCtD
Flunisolide—NR3C1—Generic Transcription Pathway—AR—prostate cancer	1.47e-05	0.000655	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—GSTT1—prostate cancer	1.47e-05	0.000651	CbGpPWpGaD
Flunisolide—Pruritus—Doxorubicin—prostate cancer	1.46e-05	0.000181	CcSEcCtD
Flunisolide—NR3C1—Generic Transcription Pathway—RXRA—prostate cancer	1.46e-05	0.00065	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—prostate cancer	1.46e-05	0.000649	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—CYP2A6—prostate cancer	1.45e-05	0.000644	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—prostate cancer	1.45e-05	0.000642	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—TGFB1—prostate cancer	1.44e-05	0.000639	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—EIF3A—prostate cancer	1.43e-05	0.000636	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—EP300—prostate cancer	1.43e-05	0.000635	CbGpPWpGaD
Flunisolide—Vomiting—Epirubicin—prostate cancer	1.42e-05	0.000175	CcSEcCtD
Flunisolide—Diarrhoea—Doxorubicin—prostate cancer	1.42e-05	0.000175	CcSEcCtD
Flunisolide—Rash—Epirubicin—prostate cancer	1.41e-05	0.000174	CcSEcCtD
Flunisolide—Dermatitis—Epirubicin—prostate cancer	1.41e-05	0.000174	CcSEcCtD
Flunisolide—Headache—Epirubicin—prostate cancer	1.4e-05	0.000173	CcSEcCtD
Flunisolide—CYP3A4—Metapathway biotransformation—AKR1C3—prostate cancer	1.39e-05	0.000618	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—CYP17A1—prostate cancer	1.39e-05	0.000616	CbGpPWpGaD
Flunisolide—Dizziness—Doxorubicin—prostate cancer	1.37e-05	0.000169	CcSEcCtD
Flunisolide—CYP3A4—Metapathway biotransformation—CYP17A1—prostate cancer	1.37e-05	0.000608	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—VEGFA—prostate cancer	1.35e-05	0.000602	CbGpPWpGaD
Flunisolide—Nausea—Epirubicin—prostate cancer	1.33e-05	0.000164	CcSEcCtD
Flunisolide—NR3C1—Generic Transcription Pathway—VDR—prostate cancer	1.32e-05	0.000589	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—NCOA2—prostate cancer	1.32e-05	0.000587	CbGpPWpGaD
Flunisolide—Vomiting—Doxorubicin—prostate cancer	1.32e-05	0.000162	CcSEcCtD
Flunisolide—Hydrocortisone—CYP3A4—prostate cancer	1.31e-05	0.0049	CrCbGaD
Flunisolide—Rash—Doxorubicin—prostate cancer	1.3e-05	0.000161	CcSEcCtD
Flunisolide—Dermatitis—Doxorubicin—prostate cancer	1.3e-05	0.000161	CcSEcCtD
Flunisolide—Headache—Doxorubicin—prostate cancer	1.3e-05	0.00016	CcSEcCtD
Flunisolide—CYP3A4—Biological oxidations—CYP2E1—prostate cancer	1.23e-05	0.000547	CbGpPWpGaD
Flunisolide—Nausea—Doxorubicin—prostate cancer	1.23e-05	0.000152	CcSEcCtD
Flunisolide—CYP3A4—Metapathway biotransformation—CYP2E1—prostate cancer	1.21e-05	0.00054	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—DNMT3B—prostate cancer	1.2e-05	0.000535	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—RPL10—prostate cancer	1.18e-05	0.000525	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—CYP1B1—prostate cancer	1.17e-05	0.000519	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—HIST1H2BG—prostate cancer	1.16e-05	0.000515	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—CYP1B1—prostate cancer	1.15e-05	0.000512	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—GGT1—prostate cancer	1.13e-05	0.000503	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—HIST1H4H—prostate cancer	1.12e-05	0.000497	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—NPPA—prostate cancer	1.12e-05	0.000497	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—PPARA—prostate cancer	1.12e-05	0.000496	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—NCOA1—prostate cancer	1.11e-05	0.000495	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—MED12—prostate cancer	1.1e-05	0.000489	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—CYP19A1—prostate cancer	1.1e-05	0.000488	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—IL6—prostate cancer	1.08e-05	0.000482	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—CYP19A1—prostate cancer	1.08e-05	0.000481	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—RXRA—prostate cancer	1.06e-05	0.000471	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—COMT—prostate cancer	1.02e-05	0.000454	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—GSTP1—prostate cancer	1.02e-05	0.000451	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—ESR1—prostate cancer	1.01e-05	0.00045	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—COMT—prostate cancer	1.01e-05	0.000447	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—GSTP1—prostate cancer	1e-05	0.000445	CbGpPWpGaD
Flunisolide—Dexamethasone—CYP3A4—prostate cancer	9.78e-06	0.00365	CrCbGaD
Flunisolide—Dexamethasone—PTGS2—prostate cancer	9.58e-06	0.00358	CrCbGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—IL6—prostate cancer	9.36e-06	0.000416	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—RPS19—prostate cancer	9.36e-06	0.000416	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—GSTM1—prostate cancer	9.33e-06	0.000415	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—GSTM1—prostate cancer	9.21e-06	0.000409	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—DNMT1—prostate cancer	8.95e-06	0.000398	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—CREBBP—prostate cancer	8.87e-06	0.000394	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—CYP1A1—prostate cancer	8.85e-06	0.000393	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—NCOA2—prostate cancer	8.78e-06	0.00039	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—HAO1—prostate cancer	8.73e-06	0.000388	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—CYP1A1—prostate cancer	8.73e-06	0.000388	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—EZH2—prostate cancer	8.67e-06	0.000385	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—PARP1—prostate cancer	8.48e-06	0.000377	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—SERPINE1—prostate cancer	8.32e-06	0.00037	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—ESR2—prostate cancer	8.03e-06	0.000357	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—HSPA1A—prostate cancer	8.03e-06	0.000357	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—NCOA1—prostate cancer	7.4e-06	0.000329	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CSAD—prostate cancer	7.12e-06	0.000316	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CBR1—prostate cancer	7.12e-06	0.000316	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ADI1—prostate cancer	7.12e-06	0.000316	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—TST—prostate cancer	7.12e-06	0.000316	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PSAT1—prostate cancer	7.12e-06	0.000316	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GRHL1—prostate cancer	7.12e-06	0.000316	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—AR—prostate cancer	7.1e-06	0.000315	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—RXRA—prostate cancer	7.04e-06	0.000313	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—UGT2B17—prostate cancer	6.62e-06	0.000294	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—UGT2B15—prostate cancer	6.62e-06	0.000294	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CKMT2—prostate cancer	6.62e-06	0.000294	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GRHPR—prostate cancer	6.62e-06	0.000294	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—SIRT1—prostate cancer	6.47e-06	0.000288	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—VDR—prostate cancer	6.38e-06	0.000283	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—NAGLU—prostate cancer	6.22e-06	0.000277	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—MBTPS1—prostate cancer	6.22e-06	0.000277	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PGAM2—prostate cancer	6.22e-06	0.000277	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—SULT2B1—prostate cancer	6.22e-06	0.000277	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—AOX1—prostate cancer	6.22e-06	0.000277	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—RFK—prostate cancer	6.22e-06	0.000277	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GSTM3—prostate cancer	6.22e-06	0.000277	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CYP3A43—prostate cancer	5.9e-06	0.000262	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—AMACR—prostate cancer	5.9e-06	0.000262	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—NAT1—prostate cancer	5.9e-06	0.000262	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—SRD5A2—prostate cancer	5.9e-06	0.000262	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—DEGS1—prostate cancer	5.9e-06	0.000262	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—ERCC2—prostate cancer	5.83e-06	0.000259	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—HSD17B1—prostate cancer	5.63e-06	0.00025	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—PPARA—prostate cancer	5.38e-06	0.000239	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—MYC—prostate cancer	5.26e-06	0.000234	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—HPGD—prostate cancer	5.02e-06	0.000223	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—B4GALT4—prostate cancer	5.02e-06	0.000223	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—ESR1—prostate cancer	4.87e-06	0.000217	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—TNFRSF21—prostate cancer	4.72e-06	0.00021	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—MTAP—prostate cancer	4.59e-06	0.000204	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CYP7B1—prostate cancer	4.59e-06	0.000204	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—SULT1E1—prostate cancer	4.47e-06	0.000199	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—SRD5A1—prostate cancer	4.47e-06	0.000199	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—CREBBP—prostate cancer	4.27e-06	0.00019	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—HSD17B3—prostate cancer	4.26e-06	0.00019	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ACSL4—prostate cancer	4.26e-06	0.00019	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—UMPS—prostate cancer	4.09e-06	0.000182	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PHGDH—prostate cancer	4.09e-06	0.000182	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ARG2—prostate cancer	4.09e-06	0.000182	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—LDHB—prostate cancer	4.01e-06	0.000178	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—SERPINE1—prostate cancer	4e-06	0.000178	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CYP3A5—prostate cancer	3.94e-06	0.000175	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PDHA1—prostate cancer	3.8e-06	0.000169	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—UCP3—prostate cancer	3.8e-06	0.000169	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—TCN2—prostate cancer	3.8e-06	0.000169	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GSTA3—prostate cancer	3.8e-06	0.000169	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—HSD3B1—prostate cancer	3.63e-06	0.000161	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—SLC22A3—prostate cancer	3.63e-06	0.000161	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—TBXAS1—prostate cancer	3.48e-06	0.000154	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GSTA4—prostate cancer	3.48e-06	0.000154	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GSTA2—prostate cancer	3.39e-06	0.000151	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—SULT1A1—prostate cancer	3.35e-06	0.000149	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ABCG5—prostate cancer	3.35e-06	0.000149	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GSTA1—prostate cancer	3.27e-06	0.000145	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—HSD3B2—prostate cancer	3.23e-06	0.000144	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—NAT2—prostate cancer	3.23e-06	0.000144	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GSTO1—prostate cancer	3.23e-06	0.000144	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PLCB2—prostate cancer	3.1e-06	0.000138	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CYP2C18—prostate cancer	3.1e-06	0.000138	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—LRP2—prostate cancer	3.1e-06	0.000138	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—P4HB—prostate cancer	3.04e-06	0.000135	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—SLC22A1—prostate cancer	2.96e-06	0.000131	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—SULT2A1—prostate cancer	2.88e-06	0.000128	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—MED12—prostate cancer	2.83e-06	0.000126	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GNG5—prostate cancer	2.81e-06	0.000125	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—NCOA3—prostate cancer	2.71e-06	0.00012	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—HPGDS—prostate cancer	2.58e-06	0.000115	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CYP2C19—prostate cancer	2.57e-06	0.000114	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—MYC—prostate cancer	2.53e-06	0.000113	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ACHE—prostate cancer	2.51e-06	0.000111	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GSTT1—prostate cancer	2.51e-06	0.000111	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CYP2A6—prostate cancer	2.48e-06	0.00011	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—AKR1C3—prostate cancer	2.41e-06	0.000107	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PRKACB—prostate cancer	2.4e-06	0.000107	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CYP17A1—prostate cancer	2.37e-06	0.000105	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—NCOA2—prostate cancer	2.26e-06	0.0001	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—SLC5A5—prostate cancer	2.16e-06	9.58e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CYP2E1—prostate cancer	2.11e-06	9.36e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—NQO1—prostate cancer	2.08e-06	9.26e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—TH—prostate cancer	2.05e-06	9.12e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CYP1B1—prostate cancer	2e-06	8.87e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GGT1—prostate cancer	1.93e-06	8.59e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—NCOA1—prostate cancer	1.9e-06	8.47e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.88e-06	8.34e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—RXRA—prostate cancer	1.81e-06	8.05e-05	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—AKT1—prostate cancer	1.76e-06	7.81e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—COMT—prostate cancer	1.75e-06	7.76e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GSTP1—prostate cancer	1.74e-06	7.72e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ITPR1—prostate cancer	1.71e-06	7.6e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—TYMS—prostate cancer	1.61e-06	7.18e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GSTM1—prostate cancer	1.6e-06	7.09e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—LPL—prostate cancer	1.57e-06	6.96e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.51e-06	6.72e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ERCC2—prostate cancer	1.5e-06	6.67e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—MTHFR—prostate cancer	1.41e-06	6.27e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PPARA—prostate cancer	1.38e-06	6.15e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CAV1—prostate cancer	1.3e-06	5.78e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.19e-06	5.27e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—INS—prostate cancer	1.12e-06	4.99e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CREBBP—prostate cancer	1.1e-06	4.88e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.04e-06	4.63e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—NOS3—prostate cancer	9.84e-07	4.37e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PIK3CB—prostate cancer	9.08e-07	4.04e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PTGS2—prostate cancer	9e-07	4e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PTEN—prostate cancer	7.85e-07	3.49e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—EP300—prostate cancer	7.48e-07	3.33e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PIK3CA—prostate cancer	5.54e-07	2.46e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—AKT1—prostate cancer	4.52e-07	2.01e-05	CbGpPWpGaD
